SCHEMBL12468934

SCHEMBL12468934

NC(=O)OCC#Cc1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
EGLN1 Q9GZT9 4/20 0.43
EGLN3 Q9H6Z9 1/20 0.43
SLC1A5 Q15758 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CHRM2 P08172 2/20 0.38
CHRM1 P11229 2/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM3 P20309 1/20 0.38
LMNA P02545 2/20 0.37
ALDH1A1 P00352 2/20 0.37
RAB9A P51151 1/20 0.37
ACACB O00763 1/20 0.37
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KCNH2 Q12809 1/20 0.36
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL75802 0.83 CYP2D6 (0.45) EGLN1EGLN3SLC1A5PTGDR2MEN1
SCHEMBL14784333 0.82 CYP1A2 (0.48) CYP1A2LMNARAB9ACYP2C9CYP2C19
SCHEMBL10362542 0.75 LMNA (0.49) EGLN1SLC1A5PTGDR2MEN1KMT2A
SCHEMBL75765 0.75 PTGDR2 (0.51) EGLN1SLC1A5PTGDR2MEN1KMT2A
SCHEMBL27234459 0.74 ESR1 (0.44) EGLN1SLC1A5CHRM2LMNAALDH1A1
SCHEMBL25437999 0.73 GRM5 (0.38) CYP1A2EGLN1EGLN3CYP2C19
SCHEMBL12016065 0.72 LMNA (0.46) MEN1KMT2ACHRM2CHRM1LMNA
SCHEMBL17555048 0.71 LMNA (0.43) CYP1A2EGLN1SLC1A5PTGDR2MEN1
SCHEMBL25199212 0.71 PTGDR2 (0.46) EGLN1PTGDR2MEN1KMT2ALMNA
SCHEMBL6774688 0.70 NPC1 (0.42) PTGDR2MEN1KMT2ACHRM1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2627181-A2 HETEROARYLS AND USES THEREOF Millennium Pharmaceuticals, Inc. (US) 2013-08-21 EP disclosed
WO-2012051410-A2 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-04-19 WO disclosed